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which pretreatment assessment is shown to contribute to beneficial therapeutic outcome (Hayes et aI., 1987).
In the present study, archival data were examined for 56 clients in an outpatient university training clinic.
Matched pairs were identified in which one of the clients received the MMPI-2 during the early portion of
therapy, and the other client did not receive the measure at any time. Upon comparing treatment outcomes for
the two groups, there were no significant differences in symptom reduction between clients who did and did
not complete pretreatment assessment with the MMPI-2. This result is consistent with a general lack of
evidence for the treatment utility of the MMPI in previous research. Future research might best consider
whether client or situational variables moderate any treatment utility of MMPI-2 data.
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ABSTRACT 
This study examined the treatment utility of the Minnesota Multiphasic 
Personality Inventory-2 (MMPI-2) as an aid in treatment planning. Treatment utility in 
the context of treatment planning refers to the degree to which pretreatment assessment is 
shown to contribute to beneficial therapeutic outcome (Hayes et aI., 1987). In the present 
study, archival data were examined for 56 clients in an outpatient university training 
clinic. Matched pairs were identified in which one of the clients received the MMPI-2 
during the early portion of therapy, and the other client did not receive the measure at any 
time. Upon comparing treatment outcomes for the two groups, there were no significant 
differences in symptom reduction between clients who did and did not complete 
pretreatment assessment with the MMPI-2. This result is consistent with a general lack of 
evidence for the treatment utility of the MMPI in previous research. Future research 
might best consider whether client or situational variables moderate any treatment utility 
of MMPI-2 data. 
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INTRODUCTION 
Psychological assessment is the distinguishing service provided by clinical 
psychologists, separating members of the discipline from members of related fields such 
as social work, counseling psychology, or even psychiatry. Assessment is considered a 
core competency of clinical psychologists. Practitioners use assessment instruments for 
varied purposes. Meehl (1959) delineated three broad functions of clinical assessment: 1) 
formal diagnosis (the attachment of categorical labels); 2) prognosis; and 3) personality 
assessment, including phenotypic and genotypic descriptions of personality. Within the 
area of prognosis, specific uses include prediction of response to therapy, prediction of 
clinically-relevant behaviors, and treatment planning. A final clinical application of 
assessment is the evaluation of treatment outcomes through the test-retest method. 
The present focus is on the usage of assessment instruments for treatment 
planning. Psychological treatment planning has received increasing attention in recent 
years. Makover (1992) defined treatment planning as "an organized conceptual effort to 
design a program outlining in advance the specific steps by which the therapist will help 
the patient recover from his or her presenting dysfunctional state" (p. 338). The apparent 
benefits of assessment as an aid in the treatment planning process are numerous: 
Empirical assessment can contribute to accurate diagnosis, identify client characteristics 
and needs, suggest appropriate treatment modality, and evaluate a client's readiness for 
therapy. Butcher (1990) emphasized the role of assessment in providing feedback to the 
client: "Psychological test results provide a valuable framework from which clients can 
... _--_. _._- ----_ . .. _ ----- - _._.---_._----_._ .. .. ---_._--_ .. _ .._------- --
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obtain information about themselves" (p. 5). Pretreatment assessment has also been 
demonstrated to contribute to a positive working alliance between therapist and client 
(Ackerman, Hilsenroth, Baity, & Blagys, 2000; Hilsenroth, Peters, & Ackerman, 2004). 
Researchers have suggested that with the increasing diversity and specificity of 
empirically supported treatments (ESTs), the need for guidance by assessment 
instruments is more critical than ever (Nelson-Gray, 2003; Hayes, Nelson, & Jarrett, 
1987). 
Challenges to Psychological Assessment 
Based on the evidence in favor of empirical assessment as an aid in treatment · 
planning, authors in the past decade predicted that comprehensive pretreatment 
assessment would take on an even greater role (Moreland, Fowler, & Honaker, 1994; 
Strupp, 1990). However, the predicted trend has failed to materialize (Ben-Porath, 1997). 
Several factors appear to be responsible for psychologists' decreasing usage of 
comprehensive assessment methods. The most frequently cited factor is the current 
managed-care system. As Acklin (1996) bluntly stated, "the climate for traditional 
personality assessment in the United States has changed for the worse." Psychological 
assessment is often viewed as a candidate for elimination in the interest of cost-
containment (Ben-Porath, 1997). 
Eisman et al. (2000) discussed several challenges faced by psychologists who 
wish to use assessment techniques. A prevailing view among managed care organizations 
(MCOs) is that psychological assessment is unnecessary for proper diagnosis and 
treatment. MCOs have relied instead on diagnostic interviews to serve such purposes. 
Furthermore, psychologists have experienced difficulty receiving pre authorization for 
2 
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assessment services and reimbursement following assessment. Clinical decisions about 
which instruments to use are often made by individuals who are not psychologists or do 
not have expertise in the area of assessment. 
Based on the recent threats to the practice of psychological assessment, 
researchers have identified research regarding the validation of testing and assessment 
procedures as a critical priority for the field (Meyer, 2006). As part of a work group 
commissioned by the American Psychological Association, Meyer et a1. (2001) 
summarized evidence from over 125 meta-analyses, concluding that psychological test 
validity is strong and compelling. However, psychologists have generally been 
unsuccessful in communicating the efficacy of assessment procedures to individuals 
outside of the field (Butcher, 1997). 
Treatment Utility 
The "era of accountability" dictated by the current managed care environment 
necessitates that psychologists demonstrate not only the statistical reliability and validity 
of assessment measures, but also the practical utility of such techniques. Investigation of 
the practical benefits of assessment will allow psychologists to build a science of 
assessment (Hunsley, 2002), and to provide evidence regarding the costs and benefits of 
psychological assessment, as called for by Yates and Taub (2003). The need to 
demonstrate the practical advantages of assessment has long been recognized. Meehl 
(1959) proposed four levels of validity for the clinical application of assessment data. The 
first level concerns the accuracy of the statements which can be reliably derived from a 
test. The second level considers the extent to which a test provides accurate data which 
cannot be easily obtained through more cost-efficient methods. The third level is related 
3 
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to timeliness: how much earlier does a test enable us to derive conclusions, as compared 
to nonpsychometric information-gathering methods? Finally, and most importantly, to 
what extent does the timely information provided by the test help us in treating the 
patient? Meehl stated that this last form of test validity is "ultimately the practically 
significant one by which the contribution of our techniques must be judged" (p. 107). He 
noted that no empirical evidence of the time demonstrated such validity. However, Meehl 
believed it to be "well within the capacity of available research methods and clinical 
facilities to determine what, if any, is the pragmatic advantage of a personality 
assessment being mown in advance by the therapist" (p. 116). 
Twenty eight years following Meehl's (1959) seminal paper, Hayes, Nelson, and 
Jarrett (1987) renewed the call for research investigating the effects of assessment on 
treatment outcome. The authors proposed the phrase treatment utility to refer to "the 
degree to which assessment is shown to contribute to beneficial treatment outcome" (p. 
963). They acknowledged that such research continued to be rare, but hypothesized that 
the field of clinical psychology was "intellectually ready to tackle the treatment utility of 
assessment" (p. 965). 
Treatment utility relates closely to incremental validity. Research on the 
incremental validity of a test evaluates whether the addition of data obtained by the test to 
other information leads to an increase in validity (Garb, 2003). In the context of treatment 
planning, psychologists wishing to use a certain test should be able to demonstrate that 
the addition of that test to other forms of data collected at the beginning of treatment 
(such as diagnostic interviews or brief symptom measures) results in some improvement. 
Such improvement may be observed as increased diagnostic accuracy, increased 
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predictive ability, or improved treatment outcome. It is this latter criterion that is 
associated with treatment utility. Specifically, treatment utility may be considered a 
specific subtype of incremental validity, in which an assessment procedure is 
demonstrated to contribute to beneficial treatment outcome beyond that achieved when 
the procedure is not used, with other conditions held constant. 
Treatment utility may be evaluated through several research designs. Three 
general methodologies have been identified (Hayes, Nelson, & Jarrett, 1987; Nelson-. 
Gray, 2003). In a manipulated assessment design, subjects are divided randomly into two 
or more groups, and either the collection or the availability of assessment data is varied 
between the groups. A second experimental methodology is manipulated use of 
assessment information, in which the same assessment information is available for all 
subjects, but the researcher manipulates how the information is used between groups. In a 
third experimental methodology, obtained differences, subjects are divided into groups 
nomandomly on the basis of assessment differences. All subjects receive the same 
treatment, and treatment utility is demonstrated if outcome differs between the two 
groups. 
Given the numerous articles that have been written to emphasize the importance 
of treatment utility research, and the well-defined methodologies available to conduct it, 
it is somewhat surprising that studies demonstrating the treatment utility of assessment 
continue to be rare. Nelson-Gray (2003) concluded a recent review of treatment utility 
research with the assertion that, for most assessment procedures and devices, the question 
of treatment utility has not been answered. Finn and Tonsager (1997) lamented that "we 
must conclude, as have others, that empirical evidence for the treatment utility of 
5 
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assessment is weaker than any of us might want" (p. 375). They noied that even 
comprehensive reviews have "revealed no replicated studies in which pretreatment 
assessment. .. yielded significantly better outcomes than treatments conducted without 
the benefit of psychological assessment" (p. 375). The lack of positive findings for 
treatment utility may simply reflect a lack of research in the area. Meyer (2003) noted 
that "almost no research has tried to determine whether clinical personality assessment 
helps the clients who receive an evaluation" (p. 2). 
Treatment Utility and the MMPI-2 
This study will examine the treatment utility of the restandardized Minnesota 
Multiphasic Personality Inventory (MMPI-2; Butcher, Dahlstrom, Graham, Tellegen, & 
Kaemmer, 1989). The original MMPI was published in 1943 (Hathaway & McKinley, 
1943) as a self-report measure designed to increase diagnostic accuracy. Since that time it 
has become the most widely-researched measure in the history of clinical psychology. 
The MMPI-2, published in 1989, continues to generate research interest. It is also the 
most widely used personality inventory in clinical practice (Lima et al., 2005). Obtained 
codetypes on the MMPI-2 have been demonstrated to correlate highly with codetypes on 
the original MMPI (Arbisi, Ben-Porath, & McNulty, 2003; Greene, Gwin, & Staal, 
1997). Therefore, for the purpose of this paper, no distinction will be made between data 
based on the original MMPI and those based on the MMPI-2. 
The MMPI is frequently used in treatment planning. The topic has been treated in 
numerous book chapters, articles, and volumes (e.g., Butcher, 1990; Greene & Clopton, 
2004; Klump & Butcher, 1997; Perry, Miller, & Klump, 2006). Among objective 
personality instruments, the MMPI is especially well-suited for use in treatment planning. 
6 
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One reason is that the MMPI is rooted in differential diagnosis; it is commonly accepted 
that accurate diagnosis is essential to effective treatment. Furthermore, the extensive 
body of research data regarding MMPI codetypes has been summarized in several 
"cookbooks" (e.g., Friedman, Lewak, Nichols, & Webb, 2001), which facilitate the rapid 
generation of meaningful hypotheses about clients. Finally, the MMPI-2 includes a 
Negative Treatment Indicators (TRT) scale, which can inform the therapist regarding 
clients' motivation and willingness to engage in therapy. 
Perry, Miller, and Klump (2006) identified several benefits of using the MMPI-2 
in treatment planning. Benefits to the therapist include the breadth of information that can 
be gathered (and interpreted) in relatively little time, guidance in choosing the best 
treatment modality for an individual, and the opportunity to observe client reactions to 
MMPI feedback. Perry and colleagues suggested that the MMPI-2 can serve as a useful 
resource for psychologists to use in communicating with insurance companies and to 
justify treatment decisions. Suggested benefits to the client included the identification of 
problem areas of which the client is not completely aware, and the development of 
therapeutic alliance during assessment. 
A tremendous body of research supports the use of the MMPI in treatment 
planning and evaluation. Rouse, Sullivan, and Taylor (1997) compiled a bibliography of 
over 1000 studies in which the MMPI demonstrated utility in the context of various 
treatment modalities, including cognitive-behavioral and psychodynamic, and in the 
treatment of various conditions. However, most of the studies cited provide only indirect 
evidence for the treatment utility of the MMPI. For example, the MMPI has evidenced 
ability to predict treatment outcome by distinguishing among differentially-responding 
------------- ------- - - -
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groups (Belding, Iguchi, Morral, & Husband, 1998; Chisholm, Crowther, & Ben-Porath, 
1997). Further studies have demonstrated that access to MMPI data increased the 
accuracy of clinical decisions and diagnosis (Blais, Hilsenroth, Castlebury, Fowler, & 
Baity, 2001; Schwartz & Wiedel, 1981; Trull, Useda, Costa, & McCrae, 1995). Although 
such studies demonstrate the usefulness of the MMPI in treatment planning, they do not 
provide evidence that treatment outcome itself was improved through use of the MMPI. 
As with evidence for the treatment utility of psychological assessment in general, 
there is little empirical evidence demonstrating significantly better outcomes in 
psychotherapy for patients whose treatment was guided by the MMPI. Perry, Miller, & 
Klump (2006) concluded a recent chapter on treatment planning with the MMPI-2 by 
noting that "of particular benefit would be large-scale, randomized, controlled studies in 
which treatment outcomes could be objectively compared for patients whose courses of 
therapy was guided by MMPI-2 test results and for those whose courses of therapy were 
not influenced by such test findings" (p. 164). 
Therapeutic Assessment 
The few studies that have provided direct treatment utility evidence for the MMPI 
have incorporated Finn's (1996) model of therapeutic assessment (TA). In TA, 
assessment is seen as a short-term intervention with the potential to effect therapeutic 
change. Clients are engaged as collaborators in the assessment process and are provided 
with extensive feedback following assessment. Finn and Tonsager (1997) contrasted the 
TA model with the traditional "information-gathering model," in which clinicians use 
assessment techniques primarily to gather data. The data is interpreted and 
recommendations are provided based on the clinician's unilateral decisions deduced from 
8 
the assessment results. The information-gathering model includes an emphasis on 
standardized administration, in order to allow for nomothetic interpretations. The TA 
model, in contrast, considers subjective feelings on the part of the examiner when 
meeting with the individual being tested. As a result, interpretations in the TA model 
reflect an idiographic as well as a nomothetic perspective. 
Finn & Tonsager (1992) administered the MMPI-2 and provided feedback using 
the TA model to 32 students in a college counseling center, while providing only 
examiner attention to a control group of 29 students. Compared to the control group, 
students who completed the MMPI-2 and heard their test results reported a significant 
decline in symptom distress and an increase in self-esteem at follow-up. Newman and 
Greenway (1997) conducted a similar study, but administered the MMPI-2 to the control 
group as well as the experimental group. Half of the patients received test feedback 
before outcome measurement, while feedback was delayed for the control group. 
Consistent with previous results, patients who received feedback in the TA model 
reported less symptom distress and greater self-esteem than patients who had not yet 
received feedback. 
Treatment Utility of MMPI-2 Data 
In contrast to the promising results regarding the treatment utility of the MMPI 
when used in therapeutic assessment, little research supports the ability of MMPI data 
alone to produce improved outcomes. A thorough literature review revealed only one 
study demonstrating such results (Haase & rvey, 1970, cited in Finn & Tonsager, 1997). 
Twenty-seven students at a university counseling center were randomly assigned to two 
groups. One group completed pretreatment assessment which included the original 
~~-----.­
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MMPI; the other group did not. Mter both groups received a brief course of counseling, 
the students who had completed pretreatment assessment showed greater psychological 
adjustment based on self- and therapist ratings. The authors concluded that "pretesting 
may sensitize the client to counseling, which results in greater ... client benefits than if no 
pretesting were performed" (cited in Finn & Tonsager, 1997, p. 377). 
Lima and colleagues (2005) re-examined the issue of treatment utility using the 
MMPI-2. The authors hypothesized that patients whose course of therapy was guided by 
MMPI-2 results would experience greater symptom reduction than patients whose 
therapists did not have access to such data. In a manipulated assessment design, the 
MMPI-2 was administered to 134 patients in an outpatient community mental health 
clinic. Therapist access to the test results was manipulated through random assignment to 
either an access group or to a no-access group. Therapists in the access group interpreted 
and provided feedback to patients regarding MMPI-2 results. Therapists in the no-access 
group did not view MMPI-2 results. Patient outcomes were evaluated by illness severity 
ratings, improvement ratings, number of sessions attended, and premature termination. 
The authors reported null finding for three of four indices. On the fourth index, patients 
whose therapists had access to MMPI-2 data reported greater symptom severity at 
termination than patients in the no-access condition, contrary to the authors' hypothesis. 
Based on the above findings, Lima and colleagues (2005) suggested that the 
MMPI-2 may not provide incremental validity over the other assessment measures used 
by therapists in the clinic. The authors did not specify what other assessment measures 
were included in the battery and emphasized that the study did not attempt to examine 
whether the MMPI-2 was useful in lieu of the other measures. Lima et al. postulated 
- - _._- --------- _ .. _--_.------------- _ ._ .. _-- --
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several possible explanations for their null findings. Therapists in the no-access group 
may have garnered information from other assessment measures that was similar to that 
provided by the MMPI-2. This hypothesis is difficult to evaluate given that the additional 
measures were not identified. The authors suggested, as a second possibility, that the 
MMPI-2 did not provide treatment-relevant information for therapists who had access to 
MMPI-2 profiles. Third, the authors stated that MMPI-2 results may have actually served 
as a distraction from more crucial information, such as diagnoses. Given MMPI's roots in 
differential diagnosis, this third hypothesis seems unlikely. 
Finally, Lima and colleagues (2005) suggested that the impact of assessment 
information may be limited by the use of empirically supported treatments (ESTs). This 
final hypothesis is important to consider, given the current emphasis on ESTs within the 
field of clinical psychology. Further research is necessary to evaluate the possibility that 
the development of an EST for a given diagnosis lessens the impact of data provided by a 
personality assessment measure for patients with that diagnosis. However, it is important 
to note that the delivery of an EST, even when based on a treatment manual, requires the 
therapist to be flexible in adapting the treatment to individual patients (Haynes, 
Kaholokula, & Nelson, 1999; Kendall, Chu, Gifford, Hayes, & Nauta, 1998). 
Conceptually, there is no reason to believe that treatment based on ESTs would not 
benefit from comprehensive pre-treatment personality assessment. 
Lima et a1. (2005) noted that the reliability and generalizability of their findings 
should be established prior to drawing conclusions. A potential confound in the study 
involved the no-access group: Patients in the no-access group were offered the 
opportunity to receive feedback on their MMPI-2 results (from a clinician other than their 
11 
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therapist). Ten of the 64 patients did receive feedback, thereby blurring the boundary 
between the access and no-access groups. Although the therapists did not see results, it is 
clear that a portion of the positive impact of MMPI-2 administration is the feedback that 
patients receive. This limitation may be addressed in future research into the treatment 
utility of the MMPI-2 by only administering the test to the experimental group, which 
would eliminate the ethical obligation to provide test feedback to the control group. 
Present Study 
The purpose of this study was to continue to evaluate the treatment utility of the 
MMPI-2. Specifically, do clients in a community outpatient clinic experience better 
therapy outcomes when their course of therapy is informed by the MMPI-2? Archival 
data were utilized to compare outcomes for clients who did and did not receive the 
MMPI-2 early in their course of therapy. Based on the many perceived benefits of the 
MMPI, as well as its demonstrated ability to improve diagnostic decisions and to 
distinguish between differentially-responding groups, it was hypothesized that clients 
who received the MMPI-2 eady in their course of therapy would demonstrate greater 
symptom reduction than clients who did not receive it. 
Although it is clear that many clinicians value the MMPI-2, research has not yet 
convincingly demonstrated the treatment utility of the measure as a guide in treatment 
planning. Further investigation is essential to building the science of assessment and to 
communicating the benefits of this long-used psychological test to other health 
professionals and to managed care companies. 
-- ----~---- --- - -------- - - --- - -
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METHOD 
Participants 
Subjects were 56 adult outpatient clients at the Pacific University Psychological 
Service Center (PSC), seen at the clinic from 2001 to 2007. Half of the participants 
completed the MMPI-2 early in their course of therapy, and the other half did not 
complete the MMPI-2 at any point during treatment. The total sample consisted of 34 
females (60.7%) and 22 males (39.3%), with a mean age of 31.8 years (ranging from 20 
to 65, SD = 9.14). Information regarding ethnicity was available for only 25 (44.6%) of 
clients. Of those clients, the majority (n = 18, 72%) self-identified as Caucasian. The 
remainder identified as African American (n = 2, 8%), Hispanic (n = 1,4%), Asian 
American (n = 1,4%), or of mixed ethnicity (n = 3,12%). The predominantly Caucasian 
sample is consistent with the larger population of clients seen at the PSC, as well as 
general population demographics of the Portland area. The mean number of sessions 
received was 24.36 (SD = 18.4), ranging from 8 to 76. The mean number of sessions 
received prior to MMPI-2 administration, when present, was approximately 4 (M = 4.61, 
SD = 3.3). 
Measures 
MMPI-2 
The MMPI-2 (Butcher et al., 1989) is a self-report measure of adult 
psychopathology, consisting of 567 true or false items. Test-retest reliability coefficients 
for the individual validity and clinical scales of the MMPI-2 range from .68 to .92 for a 2-
13 
week interval, and test-retest reliability coefficients for the content scales range from .78 
to .91 (summarized in Greene & Clopton, 2004). MMPI-2 profiles are generally 
interpreted beginning with the most elevated scale(s), which make up the codetype. Large 
bodies of research facilitate rapid description and generation of hypotheses regarding 
individuals who obtain common codetypes. Because only the presence or absence of 
MMPI-2 administration was relevant to the current study, MMPI-2 data itself was not 
utilized. 
Outcome Questionnaire 45.2 (OQ-45.2) 
The 00-4S.2 (Lambert et al., 1996) is a 4S-item self-report measure of distress. 
Individuals rate the degree to which each item is true for them based on as-point likert-
type scale. The 00-45.2 is a broad measure designed to evaluate psychotherapy 
outcomes. The questionnaire is divided into three subscales: symptom distress, 
interpersonal relations, and social role. Internal consistency estimates for the subscales 
and total score range from .70 to .93, indicating good reliability (Hanson, 200S). The 00-
45.2 is routinely administered at the PSC at intake and at frequent intervals during the 
course of therapy. Only the first and last 00-4S.2 scores of each participant were used in 
the present analysis. 
Additional Forms 
The remainder of study variables were garnered from several forms used by the 
PSC. These included a contact log which documents the number and frequency of 
sessions, an intake report which presents basic client information and intake diagnoses, 
and a termination report which summarizes the therapeutic approach used for each client. 
14 
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Therapists 
Data was not collected regarding individual therapists included in the study. 
However, all therapists were clinicians at the PSC. Therapists at the PSC include doctoral 
students of clinical psychology in their first, second, and third years of practicum, as well 
as pre-doctoral interns. Each therapist receives approximately 3 hours of weekly 
supervision from a licensed clinical psychologist, in addition to monthly trainings and 
case conferences. All therapists had completed coursework on the MMPI-2. Therapists in 
the study applied treatment modalities including cognitive-behavioral, psychodynamic, 
gestalt, integrative, humanistic, existential, and interpersonal. 
Procedure 
Archival data were extracted from the closed files of former clients at the PSC, 
each of whom signed informed consent at intake authorizing the use of their treatment 
data for research. The files are maintained in locked cabinets within a secure storage 
room at the clinic. All data were collected by the primary investigator. A matched-pairs 
technique was used to select two equivalent groups. Files were examined sequentially (in 
alphabetical order by year) to identify files that met the inclusion criteria for the MMPI-2 
group. Inclusion criteria are described below. Following the collection of data for each 
MMPI-2 subject, the first file which did not include an MMPI-2 administration and fit 
matching criteria for the previous file was recorded to complete the pair. Twenty eight 
pairs were collected. 
Inclusion Criteria 
Adult clients aged 18 and up were included in the study. Each of the clients must 
have completed at least 8 therapy sessions at the PSC, not including the intake interview. 
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Valid files included an OQ-45.2 score by the first session after intake, and another OQ-
45.2 score within 4 sessions of termination. Clients in the MMPI-2 group must have 
completed the MMPI-2 within the first 8 sessions and at least 4 sessions before 
termination, or in the first one third of therapy if more than 8 sessions were received. 
Matching Criteria 
Matching to the MMPI-2 sample was based on several criteria. First, the total 
number of sessions received was within 4 sessions. Second, the initial OQ-45.2 score 
must have been within 10 points. This criterion was expanded to facilitate the matching 
of extreme scores, so that matching to initial OQ-4S.2 scores above 85 was within 15 
points, and matching to initial scores above 100 was within 20 points. Finally, clients 
were loosely matched by treatment modality, such that clients who received strictly short-
term therapy (e.g., cognitive behavioral) were not matched to clients who received 
exclusively long-term therapy (e.g., psychodynamic). Intake diagnoses were collected for 
inclusion in preliminary analyses, but were not considered in the matching process. 
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RESULTS 
Preliminary Analyses 
Before examining group differences on the outcome variable-change in 00-45.2 
score-preliminary analyses were conducted to evaluate the similarity of the two 
treatment groups. Independent t-tests revealed no significant difference between the two 
groups for initial 00-45.2 score, t(54) = -.14, P = .891, age, t(54) = -.71, P = .479, or for 
total number of sessions received, t(54) = -.04,p = .966. Chi-square procedures indicated 
no significant difference in the distribution of ethnicities between groups, i( 4, N = 25) = 
8.77,p = .067. However, group differences were noted for treatment modality received, 
x\ 4, N = 56) = 20.28, P < .001. Clients who completed the MMPI -2 were more likely to 
have received psychodynamic therapy than their counterparts, and were less likely to 
have received therapy from a Gestalt orientation. Group differences for treatment 
modality are summarized in Table 1. 
Primary intake diagnoses fell into seven categories, as summarized in Table 2. 
Chi-square analysis revealed no significant difference between groups when considering 
all diagnoses, '1:(6, N = 55) = 8.50, P = .204. The diagnoses were further coded into a 
dichotomous variable to account for the influence of severity of diagnosis. Specifically, 
the following categories of diagnosis were considered to reflect "mild" or transitory 
severity: adjustment disorders, relational problems, and other v-code diagnoses. All other 
diagnoses were considered to reflect more significant clinical presentations. Based on this 
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Table 1. 
Treatment Modality Frequencies by Group 
Treatment Modality 
Cognitive / Behavioral 
Psychod ynamic 
Gestalt 
Integrative 
Other 
Totals 
Yes 
10 
16 
o 
1 
1 
28 
MMPI-2 Given? 
No 
13 
2 
7 
3 
3 
28 
Total 
23 
18 
7 
4 
4 
56 
distinction, clients who completed the MMPI-2 were significantly more likely to have 
received significant clinical diagnoses at intake than were clients who did not complete 
the measure, X2(1, N = 55) = 5.73,p < .05. 
Main Analysis 
An independent t-test was conducted to test the hypothesis that clients who 
received the MMPI-2 would experience more symptom relief than clients who did not 
complete the MMPI-2. Symptom relief was assessed by OQ-45.2 scores at intake and at 
the conclusion of therapy. Final scores were subtracted from initial scores to create a 
single variable reflecting OQ-45.2 change over the course of therapy. Equal variances 
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Table 2 
Primary Intake Diagnosis Frequencies by Group 
MMPI-2 Given 
Primary Diagnosis Yes No Total 
Significant 
Dysthymic / Depressive 12 10 22 
Anxiety 8 4 12 
Bipolar 1 0 1 
Other significant disorder 2 0 2 
Mild 
Adjustment disorder 1 5 6 
Relational problem 2 4 6 
V -codes (non-relational) 2 4 6 
Totals 28 27a 55a 
aDiagnostic information was unavailable for one client. 
were assumed when conducting the t-test (Levene's F = 1.47,p = .231). Contrary to the 
hypothesized relationship, there was no significant difference in OQ-45.2 change for 
clients who received the MMPI-2 (M = 16.00, SD = 21.61) and those who did not (M = 
22.21, SD = 26.94), t(54) = .95,p = .345. The magnitude of differences in the mean 
scores was negligible (112 = .017). The main anaylsis is summarized in Table 3. 
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Table 3 
Independent t-test and Descriptive Statistics for OQ-45.2 Change 
MMPI-2 Given 
Variable 
OQ-45.2 change 
Yes 
M SD 
16.00 21.61 
No 
M SD t 
22.21 26.94 .95 
Post Hoc Analyses 
df 112 
54 .017 
Several analyses were conducted in order to explore the potential effects of group 
differences in treatment modality and in intake diagnosis. Symptom reduction as 
measured by the OQ-45.2 did not vary significantly as a function of the treatment 
modality received by participants when explored by a one-way ANOVA, F(4, 51) = .75, 
P = .566. Modality accounted for a small portion of the variance in outcomes (partial eta 
squared = .055). A t-test indicated that clients with "mild" intake diagnoses (Adjustment 
Disorders and V-codes) scored significantly lower on the OQ-45.2 at intake (M = 63.89, 
SD = 21.21) than did clients who received more severe diagnoses eM = 80.92, SD = 
17.29), t(53) = -3.18,p < .01. Clients with Mild and Significant diagnoses did not 
significantly differ in outcomes, t(53) = -1.30,p = .200; however, the trend was for 
clients with significant intake diagnoses to achieve greater reduction in OQ-45.2 scores 
(M = 22.46, SD = 26.30) than did clients with mild diagnoses at intake (M = 13.39, SD = 
19.40). 
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The final analyses were conducted in an effort to identify variables that predicted 
positive outcome for clients who received the MMPI-2. Only data from the MMPI-2 
group (n = 28) was included in the analyses. For such clients, t-tests revealed no 
significant difference in outcome associated with gender, t(26) = Al,p = .683, or severity 
of intake diagnosis, t(26) = -1.15, P = .261. Furthermore, one-way ANOV As indicated no 
significant differences based on treatment modality, F(3, 24) = 1.37,p = .277, or intake 
diagnosis,F(6,21) = .78,p = .592. 
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DISCUSSION 
The purpose of this study was to evaluate the treatment utility of the MMPI -2 as 
an aid in treatment planning within an outpatient training clinic. Matched pairs were 
selected from archival records at the Psychological Service Center. Each pair consisted of 
one client that had received the MMPI-2 early in the course of therapy and of a second 
client who did not receive the MMPI-2. Outcomes were evaluated by change on the OQ-
45.2, which measures general psychological distress across several domains. Contrary to 
the study hypothesis, clients who received the MMPI-2 did not achieve better therapy 
outcomes than clients who did not receive it. No significant difference was noted between 
groups. This result is consistent with findings reported by Lima et al. (2005), who found 
that systematically controlling therapists' access to their clients' MMPI-2 results did not 
generally affect outcomes. This study, therefore, represents a step toward establishing the 
reliability and generalizability of such findings. However, the current results should be 
interpreted cautiously due to several inherent limitations of the study, which are 
discussed below. 
The current null findings may be due to several factors. First, it may be that 
MMPI data did not add treatment-relevant information beyond that accessible through 
other assessment methods, including interviews and self-report measures. Second, as 
suggested by Lima and colleagues (2005), the data provided by comprehensive 
personality assessment may have less relevance within an EST paradigm. The majority of 
clients in the present study received empirically-supported therapies. Third, the therapists 
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in the study may have used MMPI inefficiently. This may have occurred due to failure to 
fully interpret MMPI data and incorporate it into treatment plans. Therapists may also 
have failed to enlist clients in the assessment process and provide meaningful feedback, 
thereby diminishing the therapeutic effects of assessment. 
It is also possible that clients who received the MMPI achieved differential 
outcomes that were not measured by the OQ-4S.2. Although the OQ-4S.2 measures a 
broad range of symptoms and areas of function, it does not assess any area in depth. It 
may be that clients who received the MMPI achieved change in a level of functioning 
that is not well represented by the current outcome measure. Furthermore, the null 
findings may reflect positively on the treatment utility of the MMPI, in that clients in the 
MMPI group were more likely to have significant clinical diagnoses and may have been 
less likely to achieve equivalent outcomes if not for the therapists' usage of MMPI data. 
However, this hypothesis is unlikely given that clients with significant diagnoses tended 
to achieve greater overall symptom reduction across both groups. 
Limitations and Considerations 
Several methodological limitations were present in the archival design of the 
current study. Because groups were not randomly assigned, it is impossible to know 
which factors contributed to some clients receiving the MMPI-2 while others did not. It is 
likely that therapist and supervisor factors played a large role in determining which 
clients received the measure. This notion is supported by the significant difference in 
treatment modalities between groups. Clients assigned to therapists of a psychodynamic 
orientation were much more likely to receive the MMPI-2. It is also possible that a 
systematic difference in the clients themselves affected the decision to administer the 
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MMPI. Indeed, clients in the MMPI group were more likely to have received 
"significant" intake diagnoses than were clients who did not receive it. The decision by 
therapists at the PSC to administer additional assessment instruments may reflect that a 
case is perceived as challenging and unusual. It is probable that, despite controlling for 
some variables, the two samples in the study were not equivalent. Any such systematic 
difference in groups, if present, would weaken the conclusions that may be drawn from 
these results. This limitation may be addressed in future research by utilizing a 
manipulated assessment methodology in which the administration of the MMPI was 
randomly varied between groups. 
A related limitation is that assessment measures apart from the MMPI were not 
controlled for. For example, some clients in the non-MMPI group may have received 
alternate personality assessment measures. Such instances were likely rare because the 
MMPI is the primary personality measure used at the PSC. However, due to this 
limitation, the present study does not address incremental validity; only the treatment 
utility ofthe MMPI independent of other measures is considered. The effects of other 
measures may have obscured the benefit provided by the MMPI. This limitation may be 
addressed in future studies by administering only the MMPI during the assessment phase 
of treatment. 
Therapists' usage of the MMPI was not measured or standardized in this study. 
However, given that each therapist decided to administer the MMPI, which is not 
routinely given at the clinic, it is likely that results were thoroughly examined and 
incorporated into treatment plans. Feedback to clients about their MMPI results also was 
not standardized, and may have differed largely from one therapist to another. Because it 
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is unknown if and how feedback was provided to each client, the therapeutic benefits of 
assessment may not be fully reflected in these results. Rather, only the treatment utility of 
MMPI data itself can be inferred. 
A further consideration is the relatively small sample size (N = 56) reflected in 
these results. Due to the limited sample size, the study did not have sufficient power to 
detect small effects. However, it is unlikely that the hypothesized relationship would have 
been found even with a large sample size, as the trend for this sample was for clients who 
did not complete the MMPI to achieve more symptom reduction than clients who did 
complete the measure. 
Finally, the sample in the present study was somewhat limited. The participants 
were largely homogenous regarding ethnicity. Although the proportion of Caucasian 
clients reflects the population in which the clinic is located, these findings may not 
generalize to populations of other ethnicities. Because the PSC is a subsidized training 
clinic, most clients are of lower- or middle-class socioeconomic status. It is necessary to 
replicate these findings with varied populations in order to improve their generalizability. 
Conclusions and Future Directions 
The current null findings are consistent with the results of Lima and colleagues 
(2005). However, it is clear that the treatment utility of the MMPI merits further 
evaluation. Given the value placed on the test by countless experienced practitioners, this 
continues to be an important area of study. At this time, the ability of the MMPI to 
predict positive treatment outcomes beyond those achieved without such assessment 
remains equivocal. The present findings bear replication and generalization in other 
settings. 
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If researchers continue to find that pre-treatment assessment with the MMPI does 
not enhance treatment outcomes, the next step is to identify circumstances in which the 
test does have utility. It may be that routine administration of the MMPI during treatment 
planning is unwarranted. Practitioners may achieve most success with the measure by 
using it selectively to answer specific questions. For example, the MMPI has been 
demonstrated to increase the accuracy of some diagnoses (Blais, Hilsenroth, Castlebury, 
Fowler, & Baity, 2001; Schwartz & Wiedel, 1981; Trull, Useda, Costa, & McCrae, 
1995); therefore, use of the test as an aid in differential diagnosis appears to be 
empirically supported in some cases. A further use of the test may be to identify 
differentially-responding groups, with the end goal of selecting the best-fitting treatment 
modality for each individual. 
The state of assessment science would benefit from research exploring the 
conditions under which the MMPI holds treatment utility. The test may be more 
meaningful for clients with certain diagnoses or of certain demographics. In the current 
study, no such variables were identified. However, such studies could be conducted by 
examining treatment outcomes for clients who did and did not receive the MMPI. Any 
variables that predicted beneficial outcome for the MMPI group but not for the other 
would be identified as areas of interest vis a vis the treatment utility of the MMPI. 
Similarly, studies may use multiple outcome assessment techniques to examine whether 
clients who receive the MMPI demonstrate positive outcome within a specific domain of 
functioning (e.g., interpersonal relationships, self-efficacy, etc.). 
Given that the treatment utility of the MMPI has been most strongly demonstrated 
within a therapeutic assessment model (c.f. Finn, 1996), it is likely that practitioners 
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would achieve maximum benefit with the measure by incorporating such techniques. 
However, this distinction bears further examination. Of particular interest would be 
studies comparing outcomes of clients who receive the MMPI in a traditional 
information-gathering model and of clients receiving therapeutic assessment with the 
MMPI. 
Although the present study has focused on the MMPI, the issues here raised may 
be applied to any psychological assessment measure or procedure. Similar methodologies 
may be applied to determine the effect of a given measure on treatment outcome. 
Consideration of the matter of treatment outcome as related to assessment is essential to 
building the science of psychological assessment. Furthermore, demonstration of the 
treatment utility of assessment techniques will allow psychologists to convincingly 
demonstrate the benefits of such practices to outside payers and to the general public. 
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